Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ICON PUBLIC LIMITED COMPANY

(ICLR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

ICON Public : plc to Present at the Wells Fargo 16th Annual Healthcare Conference and the Baird Global Healthcare Conference (Form 6-K)

09/02/2021 | 06:22am EST
ICON plc to Present at the Wells Fargo 16th Annual Healthcare Conference and the Baird Global Healthcare Conference

DUBLIN--(BUSINESS WIRE)--September 2, 2021--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at:

  • the Wells Fargo 16th Annual Healthcare Conference on Thursday, September 9, 2021 at 8.00am ET; and
  • the Baird Global Healthcare Conference on Wednesday, September 15, 2021 at 8:30am ET.

Any changes to these events and links to the live webcasts (where available) will be posted on the Investor section of our website under 'Events'.

About ICON plc

ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 16,480 employees in 89 locations in 45 countries as at June 30, 2021. For further information about ICON, visit: www.iconplc.com and www.iconplc.com/pra.

This press release contains forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, the impact of COVID-19 on our business, as well as other economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word 'expected' and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, F-4, S-8 and F-3, which are available on the SEC's website at http://www.sec.gov.

Source: ICON plc

ICON/ICLR-G

Contacts

Investor Relations
+1888 381 7923 or

Kate Haven
Vice President Investor Relations
+1 215 616 3000


Disclaimer

ICON plc published this content on 02 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 September 2021 10:21:03 UTC.


© Publicnow 2021
All news about ICON PUBLIC LIMITED COMPANY
12/07ICON named best Contract Research Organisation in latest string of awards and recogniti..
AQ
12/07ICON Named Best Contract Research Organisation in Latest String of Industry Awards
BU
11/22ICON PUBLIC : Releases Environmental, Social and Governance Report - Form 6-K
PU
11/22ICON Releases Environmental, Social and Governance Report
AQ
11/16Deutsche Bank Adjusts ICON's Price Target to $287 From $234, Maintains Hold Rating
MT
11/10ICON Announces the Expansion of its Accellacare Site Network
BU
11/10ICON Announces the Expansion of Its Accellacare Site Network
CI
11/08ICON plc to Present at the 30th Annual Credit Suisse Healthcare Conference and the 4th ..
AQ
11/05ICON plc to Present at the 30th Annual Credit Suisse Healthcare Conference and the 4th ..
PU
11/05ICON plc to Present at the 30th Annual Credit Suisse Healthcare Conference and the 4th ..
BU
More news
Analyst Recommendations on ICON PUBLIC LIMITED COMPANY
More recommendations
Financials (USD)
Sales 2021 5 495 M - -
Net income 2021 282 M - -
Net Debt 2021 4 973 M - -
P/E ratio 2021 69,3x
Yield 2021 -
Capitalization 22 661 M 22 661 M -
EV / Sales 2021 5,03x
EV / Sales 2022 3,35x
Nbr of Employees 37 960
Free-Float 99,2%
Chart ICON PUBLIC LIMITED COMPANY
Duration : Period :
ICON Public Limited Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ICON PUBLIC LIMITED COMPANY
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 278,40 $
Average target price 303,73 $
Spread / Average Target 9,10%
EPS Revisions
Managers and Directors
Stephen A. Cutler Chief Executive Officer & Executive Director
Brendan Brennan Chief Financial Officer
Ciaran Murray Executive Chairman
Tom O'Leary Chief Information Officer
Gregory P. Licholai Chief Medical & Innovation Officer
Sector and Competitors
1st jan.Capi. (M$)
ICON PUBLIC LIMITED COMPANY42.78%22 661
MODERNA, INC.171.27%114 904
LONZA GROUP AG30.52%59 816
IQVIA HOLDINGS INC.51.92%51 999
SEAGEN INC.-14.61%27 346
CELLTRION, INC.-42.20%24 169